Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NØRREBRO KIROPRAKTISK KLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   8.9% 5.4% 4.1% 5.7% 4.7% 9.5% 20.4% 15.9%   Credit score (0-100)   30 43 50 40 44 25 4 12   Credit rating   BB BBB BBB BBB BBB BB B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   939 1,210 1,128 1,386 1,275 2,162 0.0 0.0   EBITDA   62.6 125 242 701 497 101 0.0 0.0   EBIT   34.3 96.5 213 674 497 101 0.0 0.0   Pre-tax profit (PTP)   4.3 67.4 209.0 606.7 482.7 98.3 0.0 0.0   Net earnings   3.3 51.0 162.1 469.8 369.8 75.7 0.0 0.0   Pre-tax profit without non-rec. items   4.3 67.4 209 607 483 98.3 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   83.6 55.3 26.9 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   83.3 134 242 712 1,082 -22.3 -102 -102   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 8.0 102 102   Balance sheet total (assets)   435 587 546 1,481 1,405 815 0.0 0.0   Net Debt   -33.7 -112 -169 -183 -102 -768 102 102     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   939 1,210 1,128 1,386 1,275 2,162 0.0 0.0   Gross profit growth   9.1% 29.0% -6.8% 22.9% -8.0% 69.6% -100.0% 0.0%   Employees   0 0 0 0 0 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   435 587 546 1,481 1,405 815 0 0   Balance sheet change%   -10.0% 34.8% -7.0% 171.2% -5.1% -42.0% -100.0% 0.0%   Added value   34.3 96.5 213.3 673.6 496.7 100.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -32 -57 -57 -54 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.7% 8.0% 18.9% 48.6% 39.0% 4.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.5% 18.9% 37.6% 66.5% 34.4% 9.0% 0.0% 0.0%   ROI %   13.7% 88.7% 113.3% 141.1% 55.4% 18.5% 0.0% 0.0%   ROE %   1.6% 46.9% 86.1% 98.4% 41.2% 8.0% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   19.1% 22.9% 44.4% 48.1% 77.0% -2.7% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -53.8% -89.9% -69.9% -26.1% -20.6% -761.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% -35.8% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   70.8% 0.0% 0.0% 0.0% 0.0% 64.3% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   1.0 1.2 1.7 1.9 4.3 1.0 0.0 0.0   Current Ratio   1.0 1.2 1.7 1.9 4.3 1.0 0.0 0.0   Cash and cash equivalent   33.7 112.2 168.8 182.9 102.5 776.1 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -0.4 79.0 215.5 712.2 1,082.0 -22.3 -51.2 -51.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 50 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 50 0 0   EBIT / employee   0 0 0 0 0 50 0 0   Net earnings / employee   0 0 0 0 0 38 0 0